RE:RE:RE:What are we to make of this?boazklinghorn wrote: This could explain the giant revenue hole.
This would however mean that AVEENO products will now use SYMRISE's SymCalmin. And we thought CEAPRO had the better mousetrap by far;
SYMRISE's claim: "First organic product on the market with highly concentrated content of avenanthramides"